Pentacam topographic changes after Epithelium-off collagen cross-linking versus Epithelium-on collagen cross-linking in patients with keratoconus | ||||
| Sohag Medical Journal | ||||
| Article 5, Volume 22, Issue 3, October 2018, Page 33-37 PDF (59.87 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/smj.2018.31200 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Asmaa Elasmay1; Gamal Radwan1; Mohamed Elagouz2; Hatem Gamal Ammar1 | ||||
| 1Department of Ophthalmology, Faculty of Medicine, Sohag University. | ||||
| 2Department of Ophthalmology, Faculty of Medicine, Sohag University. | ||||
| Abstract | ||||
| Keratoconus is a bilateral non-inflammatory disease .One of its characteristics is reduction of biomechanical strength of cornea and stromal thinning , which gradually decreases corneal thickness and induces irregular astigmatism , myopia , corneal scaring, andreduction of visual acuity.(1)For early stages of keratoconus , one would use spectacles and contact lenses though the progression of the disease can lead to irregular astigmatism or corneal scaring, leaving no other option but corneal transplantation in about 20% of patients.(2)Corneal transplantation is an expensive procedure with many complications such as high astigmatism and graft rejection; hence, seeking for a way to halt this progressive disease seems to be of crucial importance.(3) For more than a decade, corneal cross-linking (CXL) has been considered as the only method for improvingcorneal biomechanical power.(4)Corneal collagen cross-linking (CXL) is a low-invasive treatment aimed to improve biomechanical stability in eyes with keratectasia.(5) The “standard CXL protocol” described by Wollensak and colleagues includes removal of the corneal epithelium in a diameter of 9 mm , followed by saturation of the corneal stroma using 0.1% isotonic riboflavin solution in 20% dextran.(6)This procedure is proved to be effective in increasing corneal stiffness , stabilization of keratoconus , and in some cases in improving the refractive and topographic features.Even so, the epithelial removal may lead to serious complications that include infection(7),stromal haze (8), and corneal melting (9)in addition to severe pain and decrease in vision occurring during the first days after the treatment.To avoid such complications, Boxer Wachler et al. suggested a modification of the technique by keeping the epithelium intact (epithelium-on or transepithelial CXL) (10).In this study, we sought to compare keratoconus indices before and after crosslinking either epi-off or epi-on CXL by Pentacam criteria. | ||||
|
Supplementary Files
|
||||
| References | ||||
|
1- Rabinowitz YS. Keratoconus. Surv Ophthalmol 1998;42: 297-319.
2- Krachmer JH, Feder RS, Belin MW. Keratoconus and related non inflammatory corneal thinning disorders. Surv Ophthalmol 1984; 28:293- 322.
3- Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol 1986; 101:267-73 .
4- Keratoconus: Overview and update on treatment.Middle East African J Ophthalmol 2010; 17(1): 15-20.
5- Edwards M, McGhee CN,DeanS: The genetics of keratoconus . Clin Exp Ophthalmol 2001; 29:345-51.
6- Wachtmeister L, Ingemansson SO, Moller E. Atopy and HLA antigens in patients with keratoconus. Acta Ophthalmol (Copenh) 1982; 60:113-22.
7- Adachi W, Mitsuishi Y, Terai K, et al. The association of HLA with young-onset keratoconus in Japan. Am J Ophthalmol 2002; 133:557- 9 .
8- Wang Y, Rabinowitz YS, Rotter JI, Yang H; Genetic epidemiological study of keratoconus: evidence for major gene determination. Am J Med Genet 2000;93:403-9.
9- Ihalainen A.Clinical and epidemiological features of keratoconus. Genetic and external factors in the pathogenesis of the disease. Acta Ophthalmol (Copenh) 1986; 64(Suppl.): 178.
10- Rahi A, Davies P, Ruben M, et al. Keratoconus and coexisting atopic disease. Br J Ophthalmol 1977;61:761-4.
11- Hashemi H, Mehravaran S . Day to day clinically relevant corneal elevation, thickness, and curvature parameters using the orbscan II scanning slit topographer and the pentacam scheimpflug imaging device. Middle East Aff J Ophthalmol. 2010; 17:44-55.
12- Barkana Y, Gerber Y, Elbaz U, et al. Central corneal thickness measurement with the pentacam Scheimpflug system, optical low-coherence reflectometry pachymeter and ultrasound. J Cataract Refract Surg. 2005; 31(9): 1729-35.
13- Belin M., Ambrósio R., Khachikian S., Salomão M. Keratoconus / Ectasia Detection with the Oculus Pentacam: Belin / Ambrosio Enhanced Ectasia Display. J Highlights of Ophthalmology, 2009; 35 : 5-12.
14- Holladay JT, Hill WE, Steinmueller A. Corneal power measurements using scheimpflug imaging in eyes with prior corneal refractive surgery. J Refract Surg. 2009; 25:862-8.
15- Dumitrica DM and Colin J. Indices for the detection of keratoconus. Ophtalmologia. 2010; 54(2): 19-29.
16- Holladay J., Belin M., Dick B., Ambrosio R.. Why Cataract And Refractive Surgeons Need The Pentacam, J Catract & Refract Surg. 2006; p 1-12.
17- Ambrósio R., Simonato R., Jardim D., Fontes B., Fontes P. Corneal Biomechanics, Pachymetric Progression, and Corneal Volume: Novel Indices for Detecting Ectasia and Screening Refractive Patients. SAN FRANSCICO, ASCRS, 2006; p 1-29.
| ||||
|
Statistics Article View: 238 PDF Download: 283 |
||||
